selegiline has been researched along with Cognitive Decline in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Amiri, S; Baghdadchi, Y; Gharbavi, M; Hosseini, MJ; Jafari, B; Jafari-Anarkoli, I; Mahmoudi, J; Manjili, HK | 1 |
| Jia, SY; Lv, JM; Miao, HT; Shan, YD; Wang, LY; Wang, XP; Xin, Y; Yu, ZF; Zhang, DX; Zhang, LM | 1 |
| Comley, RA; Gauthier, S; Guiot, MC; Guo, Q; Harada, R; Kang, MS; Massarweh, G; Mathotaarachchi, S; Ng, KP; Okamura, N; Pascoal, TA; Rosa-Neto, P; Shin, M; Soucy, JP; Therriault, J | 1 |
| Cho, J; Cho, S; Cho, SJ; Choi, JW; Chun, H; Hwang, SY; Jang, BK; Jo, S; Ju, YH; Kim, HJ; Kim, J; Kim, S; Kim, SW; Lee, C; Lee, CJ; Londhe, AM; Nam, MH; Oh, SJ; Pae, AN; Park, JH; Park, KD; Park, M; Shin, SJ; Song, HJ; Woo, J; Yarishkin, O; Yeon, SK | 1 |
| Almkvist, O; Carter, SF; Chiotis, K; Långström, B; Leuzy, A; Nordberg, A; Rodriguez-Vieitez, E; Saint-Aubert, L; Schöll, M; Wall, A | 1 |
| Almkvist, O; Carter, SF; Engler, H; Långström, B; Nordberg, A; Schöll, M; Wall, A | 1 |
6 other study(ies) available for selegiline and Cognitive Decline
| Article | Year |
|---|---|
Mitigated Oxidative Stress and Cognitive Impairments in Transient Global Ischemia using Niosomal Selegiline-NBP delivery.
Topics: Animals; Cognitive Dysfunction; Hypoxia; Ischemia; Neuroprotective Agents; Oxidative Stress; Rats; Selegiline; Stroke | 2022 |
NLRP3-GABA signaling pathway contributes to the pathogenesis of impulsive-like behaviors and cognitive deficits in aged mice.
Topics: Animals; Cognition; Cognitive Dysfunction; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Monoamine Oxidase Inhibitors; NLR Family, Pyrin Domain-Containing 3 Protein; NLR Proteins; Selegiline; Signal Transduction | 2023 |
Monoamine oxidase B inhibitor, selegiline, reduces
Topics: Aged; Alzheimer Disease; Aminopyridines; Autoradiography; Binding, Competitive; Brain; Cognitive Dysfunction; Drug Interactions; Female; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals; Selegiline; Supranuclear Palsy, Progressive; tau Proteins | 2017 |
Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Astrocytes; Cognitive Dysfunction; D-Amino-Acid Oxidase; Enzyme Inhibitors; gamma-Aminobutyric Acid; Humans; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Selegiline | 2019 |
Comparison of Early-Phase 11C-Deuterium-l-Deprenyl and 11C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Cerebellum; Cerebrovascular Circulation; Cognitive Dysfunction; Deuterium; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gliosis; Gray Matter; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Perfusion; Pons; Positron-Emission Tomography; Radiopharmaceuticals; Selegiline; Thiazoles | 2016 |
Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Brain; Case-Control Studies; Cognitive Dysfunction; Deuterium; Female; Fluorodeoxyglucose F18; Gliosis; Humans; Male; Middle Aged; Monoamine Oxidase; Neuropsychological Tests; Positron-Emission Tomography; Radioactive Tracers; Retrospective Studies; Selegiline; Thiazoles | 2012 |